MCT oil C8 vs C10 vs coconut oil: which fatty acid actually matters

Medium-chain triglyceride oil is sold under three overlapping product categories with very different fatty acid profiles. Pure caprylic acid (C8) raises ketones fastest and highest, capric acid (C10) is slower and milder, and coconut oil is mostly lauric acid (C12) — which behaves more like a long-chain fatty acid than an MCT. The distinction matters for both efficacy and digestive tolerance.

Chain length defines the pharmacology

Medium-chain fatty acids are defined by 6–12 carbons. Unlike long-chain fatty acids, they bypass chylomicron packaging and travel directly via portal circulation to the liver, where they are rapidly beta-oxidized. C8 (caprylic, octanoic acid) is metabolized fastest, with peak blood beta-hydroxybutyrate levels typically appearing 60–120 minutes after ingestion. C10 (capric, decanoic acid) is metabolized more slowly. C12 (lauric acid) is poorly absorbed via the portal route in humans and behaves intermediate to a long-chain fatty acid.

Ketogenic response by fatty acid type

A controlled crossover trial in healthy adults gave participants 20 mL each of C8, C10, coconut oil, or a 50:50 C8/C10 mix and measured serial beta-hydroxybutyrate over 4 hours [1]. C8 produced the largest area-under-curve ketone response (about 3x C10 and 6x coconut oil). C10 produced an intermediate ketone response. Coconut oil produced negligible ketosis at single-dose levels. A subsequent pediatric trial in childhood epilepsy used C8/C10 supplementation as part of a modified MCT ketogenic diet and confirmed ketogenic potency at clinical doses [2].

The Alzheimer cognition trials

Several small trials have tested MCT oil for cognitive function in mild Alzheimer disease, with mixed results. A 90-day trial of 20 g/day caprylic triglyceride (Axona) in 152 patients reported modest cognitive improvements in non-APOE4 carriers [3]. A subsequent open-label extension supported the signal but the parallel placebo-controlled data have not been overwhelming. The use case is hypothesis-generating, not standard of care.

Why coconut oil is not the same product

Coconut oil is approximately 47% lauric (C12), 17% myristic (C14), and only about 14% C8/C10 combined. Lauric acid behaves more like a long-chain fatty acid in humans because of its low fractional portal absorption. For practical ketogenic effect, coconut oil is essentially a saturated dietary fat with a small MCT component — not a substitute for purified MCT oil.

Tolerability differences

C8 is the most likely to cause gastrointestinal upset — cramping, nausea, and explosive diarrhea at single doses above 15–20 g. C10 is generally better tolerated, and 50:50 blends sit between the two. Starting at 5 mL once daily and titrating upward over a week is the practical compromise. Splitting doses across the day improves tolerance and produces flatter ketone curves.

Athletic performance: limited support

Trials of MCT oil for endurance performance have generally not shown ergogenic benefit at the doses humans tolerate. The metabolic substitution from fat to ketone fuel is real but does not translate to time-trial gains in trained athletes [4]. Marketing of MCT for performance outruns the underlying data.

The bottom line

If the goal is rapid, predictable ketosis or cognitive-substrate effects, C8-enriched MCT (pure C8 or C8/C10 blends) is the form that matches the published trials. Coconut oil is a culinary fat, not a clinical MCT substitute. Start low to avoid GI symptoms, and split doses if using more than 15 g per occasion.